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Abstract:  Problem  statement:  Two  cancer  patients  were  treated  with  Vernonia  amygdalina  (V. 
amygdalina) leaf extract and leaf powder. The leaf extract of V amygdalina was administered orally 
for 9 months to the first patient in response to his reception of a medical diagnosis of having traces of 
prostate cancer. Approach: This patient was also over weight by 40 kg. The V. amygdalina treatment 
eliminated the traces of prostate cancer tissue and caused the patient to lose 25 Kg excess body fat. 
Results:  During  the  treatment,  the  excess  fat  elimination  by  V.  amygdalina  leaf  extract  usually 
occurred  within  2  sec,  2  min  of  V.  amygdalina  extract  intake.  Cancer  diagnostic  screening  tests 
conducted on the patient at the end of the 9 months V. amygdalina treatment showed no traces of 
prostate cancer tissues in the patient for 5 years. The prostate cancerous tissues re-emerged and re- 
stablished themselves after 4 years of the V. amygdalina treatment. The patient took hospital-based 
orthodox treatment for one year and found that the cancer was slowly progressing. The V. amygdalina 
leaf extract treatment was repeated by the patient for 6 months to arrest and eliminate the re-established 
cancer tissues. This sec V. amygdalina treatment slowed the speed of progression of the cancer but was 
ineffective in eliminating the re-established cancer tissues. The V. amygdalina treatment was terminated 
by the patient to continue with hospital-based treatment. The prostate cancer metastasized quickly after 
the termination of the V. amygdalina treatment despite the orthodox medicine treatment and killed the 
patient a year and one month after the termination of the V. amygdalina treatment. In the second case, 
oral Vernonia amygdalina leaf extract and topically applied Vernonia amygdalina leaf powder were 
administered to a skin cancer patient who was also diabetic. The treatment was given for three months. 
During  the  treatment  V.  amygdalina  leaf-powder  applied  topically  to  the  cancer  tumor  remained 
unceasingly firmly bound to the tumor surface but produced only a 10-15% reduction in the size of the 
cancer tumor in three months. The V. amygdalina treatment brought the patient’s blood glucose level 
down from 395/100 dL to a steady 33/100 dL, in one month. The blood glucose lowering effects of V. 
amygdalina  leaf  extract  were  usually  exerted  in  2  sec,  2  min  of  extract  intake  by  the  patient.  
Conclusion/Recommendations:  The action of V. amygdalina leaf extract and powder in these cancer 
treatments show that they inhibit, scavenge and destroy cancer treatments during their early formative 
stages. The results also show that V. amygdalina leaf extract can slow down but cannot effectively 
eliminate well-established cancer tissues or completely stop them from metastasizing. 
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INTRODUCTION 
 
  Vernonia  amygdalina  leaf  which  is  locally  called 
bitter leaf is a soup vegetable which has been in use in 
Nigeria for centuries. The Igbos of south eastern Nigeria 
cherish  and  long  for  their  bitter  leaf  soup  just  as  the 
American  misses  his  chocolate  cake  or  as  the  Greek 
misses his baklava and as the Soviet Georgian misses his 
fresh home-made yogurt.
 It is the bitterness in the biter 
leaf that puts it in a separate class among all green leafy 
vegetables  used in  food .This bitterness and the leaf’s 
rich  content  of  sesquiterpene  lactones;  alkaloids; 
glycosides; essential proteins;dietary mineral elements et 
cetra, confer to bitter leaf the antiplasmodial (Varshochi 
et  al.,  2010),  anti-thrombic  (Bandyopadhyay  et  al., 
2010),  wound  healing  (Indexmedicus  Afro  Who, 
2009) and anti-cancer (Oyugi et al., 2009; Pradupsri et 
al., 2009; Prakash et al., 2011; Akah and Okafor, 2006; 
Constance  Ikoku,  2009),  properties  demonstrated  in 
various studies. Am. J. Immunol., 6 (4): 50-53, 2010 
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  The  wound  healing  effect  of  herbal  ointments 
formulated  with  the  leaves  of  Vernonia  amygdalina 
were  found  to  be  more  than  those  of  the  standard 
antibiotic  (Indexmedicus  Afro  Who,  2009).  Bitter  leaf 
extract was recommended as a very good treatment for 
prostate cancer as it increases the flow of urine, reduces 
the  painful  urination  experienced  by  the  patient  and 
regulates  the  spread  of  the  cancer  cells  (Lu  and 
Benbrook,  2006)  The  therapeutic  effects  of  V. 
amygdalina  leaf  extract  and  leaf  powder  in  the 
treatment of two cases of malignant human cancer are 
reported in this study.  
 
MATERIALS AND METHODS 
 
  Dried whole-some mature red stalked V. amygdalina 
leaf  were  extracted  with  twice  their  own  volume  of 
boiling water and sieved out as the V. amygdalina extract 
or ground  into  fine powder  as the V. amygdalina leaf 
powder.  
 
The Treatment: The V. amygdalina leaf extract was 
administered  to  the  first  patient  as  soon  as  he  was 
medically diagnosed of having traces of prostate cancer. 
This patient was 40Kg over weight. The patient took 
oral 2×33 ml of the V. amygdalina extract or 10g of the 
powder 4 times daily for 9 months .This treatment was 
taken for six months, 5years and three months later to 
eliminate the re-established cancer tissues.  
  The same V. amygdalina extract was administered 
orally in the same dosage of 2×33 mL four times daily 
for  3  months  to  a  sec  patient  who  had  an  already 
advanced  re-established  skin  cancer  tumor.  This 
patient’s facial skin cancer had formerly been surgically 
removed and had re-established itself. 
   V.  amygdalina  leaf  powder  was  initially  applied 
topically to the already cleaned surface of the skin cancer 
tumor.  This  application  of  the  V.  amygdalina  powder 
was done three-hourly every day for three months. The 
orally administered V amygdalina treatment was taken 
concurrently  with  the  topical  application  of  the  V. 
amygdalina powder the cancer tumor.  
  The variables controlled for the two cancer patients 
during their treatment included the following: 
 
Items  permitted  in  the  diet  of  the  patient:  I.  One 
quarter  of  formally  consumed  quantity  of 
carbohydrates.  ii.  An  Equivalent  of  three  quarters  of 
formally consumed quantity of carbohydrates’ worth of 
non  acidic  green  leafy  vegetables.  iii.  Normal  daily 
requirements of proteins,  fruits, vitamins and  mineral 
salts. iv. A minute quantity of fat.  
Disallowed items: Each of the two cancer patients was 
disallowed taking the following during the treatment: 
 
·  Alcohol and tobacco 
·  Oilly  foods,  food  dressings,  fruits,  vegetables, 
soups, stews, gravys  
·  Food seasoning  
·  Acidic  foods,  fruits,  vegetables,  food  spices 
(including garlic, ginger)  
·  Coffee, tea, cocoa and acidic beverages and fruit 
juices 
·  Soft  drinks  (including  malt  and  carbonated  soft 
drinks) 
·  Large quantities of carbohydrate foods especially 
complex carbohydrate foods 
 
RESULTS 
 
   The  V.  amygdalina  treatment  “Ate  up”  or 
scavenged the traces of prostate cancer tissues of the 
first  patient.  Cancer  diagnostic  screening  tests  taken 
by  the  patient  after  the  V,  amygdalina  leaf  extract 
treatment  showed  no  cancer  tissue  traces  for  four 
years during which was still on the dietary restrictions 
imposed during the V. amygdalina treatment. The V. 
amygdalina  treatment  also  reduced  the  patient’s 
obesity by 25 kg. The excess fat elimination effects of 
V. amygdalina occurred each time within 2 sec, 2 min 
of drug intake. 
  When the malignant tissues of the prostate cancer 
re-established themselves after four years of the fifst 
V. amygdalina leaf extract treatment, treatment of the 
re-established prostate cancer for six months with the 
same V. amygdalina treatment regimen that was used 
in the first treatment only succeeded in slowing down 
the progression of the course of the cancer but did not 
eliminate the re-established prostate cancerous tissues 
as screening tests showed that the cancer tissues were 
spreading.  Despite  intensive  high  quality  hospital 
based treatment the re-established cancer metastasized 
quickly and killed the patient one year and one month 
after  the  termination  of  the  sec  V.  amygdalina  leaf 
extract treatment. 
  The topically applied V. amygdalina powder firmly 
stuck to the face of the tumor to dry or shrink it  up 
(Fig.  1).  There  was  evidence  that  the  topical  V. 
amygdalina powder engaged the cancer tissue to mop it 
up as it always stuck to the face of the cancer tumor 
resisting  any  attempt  to  clean  it  off  the  face  of  the 
tumor (Fig. 1). Am. J. Immunol., 6 (4): 50-53, 2010 
 
52 
 
 
Fig. 1: (left) Vernonia amygdalina powder stuck to the 
face of the cancer tumor 
 
 
 
Fig. 2: (right)  Vernonia  amygdalina  treatment 
produced  less  than  20  and  drying  up  of 
established cancer tumor 
 
The size of the tumor  was however only reduced by 
about  10-15%  at  the  end  of  three  month’s  V. 
amygdalina treatment (Fig. 2). The patient terminated 
the V. amygdalina leaf extract treatment at three months 
and went back to hospital to excise the tumor.  
 
DISCUSSION 
 
  Cancer  tissue/tumor  inhibition  and  elimination 
effects of V. amygdalina have been obtained in various 
studies (Guruswamy and Benbrook, 2006; Sureban et 
al., 2006; Constance Ikoku, 2009), although no case of 
use  of  V.  amygdalina  to  treat  human  cancer  has  been 
reported.  A  Nigerian  born  professor  of  biology,  a 
specialist  in  Vernonia  amygdalina;  at  Jackson  State 
University,  Mississippi;  found  that  some  compounds 
from  V.  amygdalina  extracts,  were  able  to  inhibit  the 
growth of breast cancer and were also effective in other 
tumor  cells  (Oyugi  et  al.,  2009).  He  also  found  that 
multiple solvent extracts of V. amygdalina leaf of various 
polarity indexes, yielded three fractions each of which 
significantly  (p<0.05),  inhibited  breast  cancer  cell 
growth at a concentration of 0.1 mg
-1 mL. In his studies 
six fractions of the Vernonia amygdalina leaf extract of 
different  solvents  (chloroform,  hexane,  butanol  and 
ethyl acetate),inhibited DNA synthesis by 76, 98, 94, 
98, 98 and 96% respectively, at a concentration of 1 
mg
-1 mL  (Oyugi  et  al.,  2009).  These  fractions  had 
similar  retention  times  of  2.213,  2.17  and  2.151  min 
respectively and showed 3 distinct UV -detected peaks 
around 410,431 and 664nm (Oyugi et al., 2009). 
  The retention time of approximately 2 min obtained 
in the breast cancer inhibition study (Oyugi et al., 2009) 
coincides with the 2 sec, 2 min pharmacological action 
time observed for Vernonia amygdalina leaf extract in its 
blood sugar-lowering and excess fat elimination effects 
obtained in my two patients. 
  
CONCLUSION 
 
  The simultaneous cancer cell cytotoxicity/inhibition 
and excess body fat/excess blood sugar removal by V. 
amygdalina  leaf  extract  /powder  in  the  same  patient 
suggests  cancer  cell  penetration  and  pharmacological 
action time of 2 sec, 2 min. The actions of Vernonia 
amygdalina  leaf  extract/powder  in  these  cancer 
treatments  suggest  that  the  extract  or  powder 
recognized,  and  destroyed  or  scavenged  malignant 
prostate  cancer  cells  which  were  at  the  early  “trace” 
stage and inhibited the skin cancer tumor which was at 
an  established  stage.  This  innate  ability  of  V. 
amygdalina  leaf  extract  to  recognize  the  cancer 
patient’s  normal  body  cells  as  “self”  cells  and  to 
recognize the malignant cancerous cells as “non self” 
cells  that  must  be  destroyed/inhibited  from 
proliferating  is  a  demonstration  of  the  immune 
defence  properties  of  Vernonia  amygdalina  leaf 
extract.  The  cancer  tissue  cytotoxicity/inhibition 
effects  of  Vernonia  amygdalina  leaf  extract  and 
powder  obtained  in  these  two  therapeutic  cases  are 
concluded  to  be  a  demonstration  of  the  free  radical 
immune  defence/antibody  properties  (Barrett  and 
Blanc,  2009;  Kadhim  et  al.,  2008)  of  Vernonia 
amygdalina leaf extract and powder.  
  The  results  of  these  two  cancer  therapeutic 
applications of V. amygdalina leaf extract and powder 
together  enable  the  reporter  to  conclude  that  V. 
amygdalina leaf extract/powder is cytotoxic to or can 
“eat up” “trace” cancerous tissue but can only inhibit 
the growth and spread of established cancer tumor. The 
experience with the prostate cancer case suggests that 
when  cancer  malignancy  becomes  well  established, 
”eating  up”  of  the  cancerous  cells  by  V.  amygdalina 
leaf extract/powder does not occur at a fast enough pace 
to  meet  or  beat  the  speed  of  proliferation  of  the Am. J. Immunol., 6 (4): 50-53, 2010 
 
53 
malignant cancer cells. The compactness of established 
cancer tumor makes its penetration hard for the short 
acting V. amygdalina leaf extract/powder. 
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